接受肝移植评估患者筛查性结肠镜检查的检出率与安全性
这项回顾性观察研究纳入2004至2017年间808例肝移植前筛查患者共858次结肠镜检查,结直肠癌检出率仅0.2%、进展期腺瘤5.4%,而术后30天内临床事件显著多于对照时段,急性肾衰竭和消化道出血风险升高,尤其在晚期肝病患者中。作者认为该人群常规筛查结肠镜的风险获益比存疑,应考虑替代筛查策略。
要点
- 肝移植前筛查结肠镜的结直肠癌检出率为0.2%,进展期腺瘤为5.4%。
- 术后30天临床事件显著多于对照时段,急性肾衰竭和消化道出血风险升高。
- 腹水和MELD评分是急性肾衰竭与消化道出血的独立危险因素。
核心结论
- 肝移植前患者结肠镜筛查的结直肠癌患病率相对较低,但术后并发症如急性肾衰竭和消化道出血风险增加,尤其在晚期肝病患者中。
- 由于该人群常规进行筛查结肠镜的风险获益比似乎存疑,应考虑替代筛查策略。
研究设计与样本
- 回顾性观察研究,纳入2004至2017年间所有连续接受肝移植前筛查结肠镜检查的患者。
- 共808例患者完成858次结肠镜检查,65%为男性,中位年龄55岁(四分位距47-62),中位MELD评分15(四分位距11-18)。
- 记录术后30天内内镜与病理发现及可能与结肠镜相关的临床事件,并与30天住院对照时段比较。
主要发现
- 结直肠癌见于2例患者(0.2%),进展期腺瘤见于44例患者(5.4%)。
- 进展期肿瘤唯一独立危险因素为年龄(比值比1.072/年;95%置信区间1.031-1.115;P<0.001)。
- 术后30天内128例患者发生178起临床事件,对照时段72例患者发生101起临床事件(P<0.001)。
- 结肠镜后肾衰竭风险显著增加(P=0.001),消化道出血风险显著增加(P=0.023)。
- 腹水和MELD评分被确定为急性肾衰竭和消化道出血的独立危险因素。
临床怎么用
- 作者认为该人群常规进行筛查结肠镜的风险获益比似乎存疑,应考虑替代筛查策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Colorectal cancer (CRC) screening with colonoscopy is commonly used in patients who are candidates for liver transplantation. We initiated this study to define the risk-benefit ratio of performing screening colonoscopy in this population. A retrospective observational study of all consecutive patients undergoing colonoscopy during pre-liver transplantation screening between 2004 and 2017 was conducted. Endoscopic and pathological findings and clinical events potentially related to the colonoscopy in the 30 days after the procedure were registered and compared with a 30-day inpatient control time frame. A total of 858 colonoscopies were performed in 808 patients (65% male; median age, 55 years [interquartile range (IQR), 47-62]; median model for end-stage liver disease (MELD) score, 15 [IQR, 11-18]). CRC was found in 2 patients (0.2%), and advanced adenomas were found in 44 patients (5.4%). The only independent risk factor for an advanced neoplasm was age (odds ratio, 1.072 per year; 95% confidence interval, 1.031-1.115; P < 0.001). During the 30-day postprocedure period, 178 clinical events occurred in 128 patients compared with 101 clinical events in 72 patients in the control time frames (P < 0.001). After colonoscopy, there was a significantly increased risk for renal failure (P = 0.001) and gastrointestinal (GI) bleeding (P = 0.023). Presence of ascites and MELD score were identified as independent risk factors for acute renal failure and GI bleeding. During the study observation period, 53.5% of the screened population actually underwent liver transplantation. Conclusion: CRC screening in pre-liver transplantation patients is associated with a relatively low prevalence of CRC and an increased risk of postcolonoscopy complications such as acute renal failure and GI bleeding, especially in patients with advanced liver disease. Because the risk-benefit ratio of standard performance of a screening colonoscopy in this population appears questionable, alternative screening strategies should be considered.
引用
- Oey RC, van Tilburg L, Erler NS, et al. The Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation. Hepatology. 2019. PMID: 30767249. doi:10.1002/hep.30562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。